highrisk class medical devices / implantable devices / healthcare innovations / renewal applications / to those products / supplement applications / healthcare solutions / pharmaceuticals / pharmaceutical legislation / healthcare professionals / sustainable and accessible healthcare systems / particular device / pharmaceutical law / pharmaceutical rules / healthcare systems / similar devices / medicinal products / electrical medical device / e - m / /
Organization
Swiss National Bank / Member State Authorities’ Committee / European Union / European Parliament / European Medicines Agency / EU Council / Assessment Committee for Medical Devices / Commission of the Notified Bodies and the Conformity Assessment System / European Commission / /
The revision of the EU Medical Devices Directives The medical devices industry’s position on four key issues: revised clinical requirements, the ‘scrutiny’ procedure, the restriction of ‘hazardous substances,’